| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $20.0M | — |
| R&D Expense | $8.7M | +108.2% |
| SG&A Expense | $7.4M | +84.1% |
| Operating Income | -$16.1M | -96.4% |
| Interest Expense | $497 | +0.0% |
| Pre-tax Income | -$15.6M | -89.4% |
| Income Tax | $26K | +157.3% |
| Net Income | -$15.4M | -87.4% |
| EPS (Basic) | -$0.89 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.5M | +30.3% |
| Current Assets | $19.8M | +32.8% |
| Total Assets | $19.9M | +33.7% |
| Current Liabilities | $3.7M | +192.3% |
| Total Liabilities | $3.7M | +112.9% |
| Stockholders' Equity | $16.4M | +24.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.4M | -53.5% |
| Capital Expenditures | $52K | — |
| Investing Cash Flow | -$52K | — |
| Financing Cash Flow | $15.5M | +378.4% |
| Free Cash Flow | -$11.4M | — |
| -50.8% |
| EPS (Diluted) | -$0.89 | -50.8% |